BDR Pharma launches generic Rucaparib to treat advanced ovarian and prostate cancers
Rucaparib is launched under the brand name BDPARIB in two strengths of 200 mg and 300 mg
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.